Skip to main content

Want a detailed portfolio tracker?

Omeros (OMER) P/E (2011 - 2026)

Omeros (OMER) P/E from Mar 31, 2011 to Jun 2, 2026. The TTM Omeros (OMER) P/E is 9.16. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Omeros (OMER)

YearP/EChange
20269.16-112.52%
2025-73.14+1902.76%
2024-3.65-135.59%
202310.26+1345.68%
20220.71-65.82%
20212.08-134.47%
2020-6.02-28.96%
2019-8.48+98.07%
2018-4.28-72.01%
2017-15.29+160.98%
2016-5.86-26.24%
2015-7.94-30.60%
2014-11.45+40.50%
2013-8.15+149.15%
2012-3.27-31.42%
2011-4.77N/A

Comparison Omeros (OMER) P/E with competitors

Omeros (OMER) P/E is 9.16.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.98%
NBYStablecoin Development Corp0.10-98.88%
ENLVEnlivex Therapeutics Ltd0.15-98.36%
FGENFibroGen Inc0.24-97.38%
TRAWTraws Pharma Inc0.47-94.84%
FBIOFortress Biotech Inc0.71-92.29%
CHRSCoherus Biosciences Inc0.98-89.32%
ORMPOramed Pharmaceuticals Inc1.47-83.92%
AGENAgenus Inc2.05-77.64%
VIVSVivoSim Labs Inc2.54-72.32%
INVAInnoviva Inc3.19-65.19%
CRMDCorMedix Inc3.65-60.20%
ABEOAbeona Therapeutics Inc4.20-54.10%
VXRTVaxart Inc4.26-53.48%
CVACCureVac N.V.4.45-51.47%
SRPTSarepta Therapeutics Inc4.62-49.52%
GLPGGalapagos NV4.86-46.96%
RIGLRigel Pharmaceuticals4.92-46.30%
ZVRAZevra Therapeutics Inc4.97-45.70%
ABUSArbutus Biopharma Corp5.69-37.84%
CGENCompugen Ltd7.38-19.39%
AUPHAurinia Pharmaceuticals Inc9.25+1.00%
ACADAcadia Pharmaceuticals Inc9.59+4.67%
PLXProtalix BioTherapeutics Inc9.91+8.18%
SPROSpero Therapeutics Inc10.73+17.19%
ADMAAdma Biologics Inc11.33+23.69%
SVASinovac Biotech Ltd11.44+24.84%
TBPHTheravance Biopharma Inc11.78+28.56%
HRMYHarmony Biosciences Holdings Inc12.18+32.97%
TGTXTG Therapeutics Inc13.18+43.88%
INCYIncyte Corp13.38+46.09%
SABSSAB Biotherapeutics Inc14.06+53.47%
XOMAXOMA Corp14.95+63.15%
REGNRegeneron Pharmaceuticals Inc14.98+63.54%
PBYIPuma Biotechnology Inc15.05+64.30%
EXELExelixis Inc15.79+72.43%
NAGENiagen Bioscience Inc16.35+78.54%
CPRXCatalyst Pharmaceuticals Inc17.34+89.35%
MDXGMimedx Group Inc17.38+89.68%
ARGXArgen X SE23.07+151.87%
HALOHalozyme Therapeutics Inc23.20+153.28%
XOMAOXOMA Corp25.34+176.69%
VRTXVertex Pharmaceuticals Inc25.66+180.08%
XOMAPXOMA Corp25.67+180.24%
CTMXCytomX Therapeutics Inc25.70+180.54%
ASNDAscendis Pharma A/S26.35+187.70%
RPRXRoyalty Pharma plc - Class A27.50+200.16%
SLNOSoleno Therapeutics Inc29.02+216.76%
LGNDLigand Pharmaceuticals Inc - Class B30.19+229.54%
BMRNBiomarin Pharmaceutical Inc37.51+309.46%
APLSApellis Pharmaceuticals Inc39.02+325.99%
KRYSKrystal Biotech Inc39.70+333.37%
GMABGenmab40.20+338.90%
TECHBio-Techne Corp68.59+648.84%
VCELVericel Corp80.63+780.22%
PHARPharming Group N.V.87.74+857.85%
ALNYAlnylam Pharmaceuticals Inc124.93+1263.88%
TLXTelix Pharmaceuticals Ltd139.89+1427.17%
CORTCorcept Therapeutics Inc158.39+1629.11%